NCT05039476 is a NA clinical trial of Retinol face cream in Wrinkle, sponsored by Chemist Confessions, Inc..

Who is sponsoring NCT05039476?

NCT05039476 is sponsored by Chemist Confessions, Inc..

What drugs are being tested in NCT05039476?

Interventions in NCT05039476: Retinol face cream, Placebo face cream.

What condition does NCT05039476 study?

NCT05039476 studies Wrinkle, Aging.

Is NCT05039476 still recruiting?

NCT05039476 is currently completed. Last updated 8 February 2023.

Last reviewed 2023-02-08 · How we verify

NCT05039476

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study to Identify if Chemist Confessions Retinol Cream Works to Improve the Appearance of Early Signs of Aging.

Completed NA Last updated 8 February 2023

What this trial tests

NA trial testing Retinol face cream in Wrinkle in 35 participants. Completed in 30 November 2022.

Timeline

1 July 2022

Primary endpoint
30 November 2022

30 November 2022

Quick facts

Lead sponsor	Chemist Confessions, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	single
Primary purpose	other
Enrollment	35
Start date	1 July 2022
Primary completion	30 November 2022
Estimated completion	30 November 2022
Sites	1 location across United States

Drugs / interventions tested

Retinol face cream
Placebo face cream

Conditions studied

Wrinkle — all drugs for Wrinkle →
Aging — all drugs for Aging →

Sponsor

Chemist Confessions, Inc.

Who can join

Adults 30 to 50, female only, with Wrinkle or Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Chemist Confessions has developed a retinol cream with the aim to improve the appearance of early signs of aging, such as fine lines, dark spots, hyperpigmentation, and crow's feet. In this phase, Chemist Confessions plans to collect self-reported outcomes and photographic images to understand the assessment of the efficacy of treatment from the participant's perspective, and if participants see an improvement in their fine lines, wrinkles, dark spots, hyperpigmentation, and crow's feet.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Wrinkle

Currently open trials in the same condition.

NCT06868615 — AVAVA MIRIA General Use · NA · recruiting
NCT06571721 — The Effects of Topical Almond Oil and Tretinoin on Facial Wrinkles · NA · recruiting
NCT06385171 — Assessing the Impact of Botulinum Toxin Type A on Facial Wrinkles: A Comprehensive Clinical Investigation · recruiting
NCT06557434 — AV-23-001 AVAVA MIRIA Pilot Study · NA · active not recruiting
NCT06202274 — Clinical Study to Evaluate the Safety and Efficacy of Candela Technology · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05039476 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chemist Confessions, Inc.
Last refreshed: 8 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05039476.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing